Yahoo
    HKSE - Delayed Quote HKD

    Transcenta Holding Limited (6628.HK)

    0.715 -0.020 (-2.72%)
    At close: November 3 at 4:08:07 PM GMT+8
    Loading Chart for 6628.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer

    Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer
    PR Newswire 15d ago
    Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies

    Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies
    PR Newswire 1mo ago
    Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer

    Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer
    GlobeNewswire 6mo ago
    Transcenta Therapeutics Appoints Dr. Christopher Hwang as Head of Global Partnerships for HiCB Platform

    Transcenta Therapeutics Appoints Dr. Christopher Hwang as Head of Global Partnerships for HiCB Platform
    GlobeNewswire 7mo ago
    Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics

    Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics
    GlobeNewswire 10mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: